IFNB1 and neoplasm: Importantly, reactivation of IFN-β and IFN-γ pathways can trigger an increase in MHC I expression on tumor cells, therefore facilitating their recognition by both the innate (NK cells) and adaptive (CD8+ cytolytic T cells) immune system.